Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 32 min ago
Peer-reviewedCC BY-NC-ND 4.0Scientific Reports

GLP-1 receptor agonists counteract the detrimental effects of pasireotide on pancreatic beta-cell function and survival

7 more authors

Related

  1. Pancreatic and biliary safety signals of GLP-1 receptor agonists and tirzepatide: a disproportionality analysis of FAERS reports
    Yuanbin Wu, Ke Li, Yuhong Wang +3
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  2. Potential for GLP-1 Receptor Agonists in Irritable Bowel Syndrome
    Michael Camilleri, Alexander C. Ford
    GastroenterologyPeer-reviewedLicence not statedFull textGeneral medicinePMC
  3. Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention
    Alaa Solaiman Algazzar
    Saudi Journal of Internal MedicinePeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismDOAJ
  4. Divergent ocular safety profiles of glucagon-like peptide-1 receptor agonists: a pharmacological heterogeneity framework
    Huili Li, Shengke Peng, Daoxi Lei
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. GLP-1 Receptor Agonists Added to Statin Therapy and Cardiovascular Outcomes in ASCVD A Propensity Score-Matched Cohort Study
    S. Tah, M. Cheshire
    medRxivPreprintAll rights reservedFull textCardiovascular medicinemedRxiv
BibTeX
@article{biondi2026glp1,
  title = {{GLP-1 receptor agonists counteract the detrimental effects of pasireotide on pancreatic beta-cell function and survival}},
  author = {Giuseppina Biondi and Nicola Marrano and Martina Rella and Valerio Galasso and Giovanni Galluzzi and Anna Borrelli and Rossella D’Oria and Valentina Annamaria Genchi and Cristina Caccioppoli and Angelo Cignarelli and Anna Leonardini and Sebastio Perrini and Leonardo Vincenti and Fabrizio Aquilino and Eliano Cascardi and Samantha Chiurlia and Luigi Laviola and Francesco Giorgino and Annalisa Natalicchio},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-73563-y},
  url = {https://www.nature.com/articles/s41598-026-73563-y},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - GLP-1 receptor agonists counteract the detrimental effects of pasireotide on pancreatic beta-cell function and survival
AU  - Giuseppina Biondi
AU  - Nicola Marrano
AU  - Martina Rella
AU  - Valerio Galasso
AU  - Giovanni Galluzzi
AU  - Anna Borrelli
AU  - Rossella D’Oria
AU  - Valentina Annamaria Genchi
AU  - Cristina Caccioppoli
AU  - Angelo Cignarelli
AU  - Anna Leonardini
AU  - Sebastio Perrini
AU  - Leonardo Vincenti
AU  - Fabrizio Aquilino
AU  - Eliano Cascardi
AU  - Samantha Chiurlia
AU  - Luigi Laviola
AU  - Francesco Giorgino
AU  - Annalisa Natalicchio
PY  - 2026
DA  - 2026/10/12
JO  - Scientific Reports
DO  - 10.1038/s41598-026-73563-y
UR  - https://www.nature.com/articles/s41598-026-73563-y
SN  - 2045-2322
ER  -